These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15607253)

  • 1. Enhancement of dissolution rate of poorly soluble active ingredients by supercritical fluid processes. Part II: Preparation of composite particles.
    Perrut M; Jung J; Leboeuf F
    Int J Pharm; 2005 Jan; 288(1):11-6. PubMed ID: 15607253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles.
    Perrut M; Jung J; Leboeuf F
    Int J Pharm; 2005 Jan; 288(1):3-10. PubMed ID: 15607252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation.
    Moribe K; Tozuka Y; Yamamoto K
    Adv Drug Deliv Rev; 2008 Feb; 60(3):328-38. PubMed ID: 18006109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
    Yasuji T; Takeuchi H; Kawashima Y
    Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supercritical fluid technology: a promising approach in pharmaceutical research.
    Girotra P; Singh SK; Nagpal K
    Pharm Dev Technol; 2013 Feb; 18(1):22-38. PubMed ID: 23036159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals.
    Pasquali I; Bettini R; Giordano F
    Adv Drug Deliv Rev; 2008 Feb; 60(3):399-410. PubMed ID: 17964684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide.
    Hassan HA; Al-Marzouqi AH; Jobe B; Hamza AA; Ramadan GA
    J Pharm Biomed Anal; 2007 Oct; 45(2):243-50. PubMed ID: 17630246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-pot method to enhance dissolution rate of low solubility drug molecules using dispersion polymerization in supercritical carbon dioxide.
    Galia A; Scialdone O; Filardo G; Spanò T
    Int J Pharm; 2009 Jul; 377(1-2):60-9. PubMed ID: 19439168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.
    Vogt M; Kunath K; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):330-7. PubMed ID: 17574401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A three step supercritical process to improve the dissolution rate of eflucimibe.
    Rodier E; Lochard H; Sauceau M; Letourneau JJ; Freiss B; Fages J
    Eur J Pharm Sci; 2005 Oct; 26(2):184-93. PubMed ID: 16081259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of supercritical solution rapid expansion technology in preparation of fine pharmacal particles].
    Zhang ZY; Li HL; Lei ZJ
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1933-6. PubMed ID: 17348181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are pharmaceutics really going supercritical?
    Pasquali I; Bettini R
    Int J Pharm; 2008 Dec; 364(2):176-87. PubMed ID: 18597957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrins as pharmaceutical solubilizers.
    Brewster ME; Loftsson T
    Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supercritical fluid particle design for poorly water-soluble drugs (review).
    Sun Y
    Curr Pharm Des; 2014; 20(3):349-68. PubMed ID: 23651403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification method development for chiral separation in supercritical fluid chromatography with the solubilities in supercritical fluid chromatographic mobile phases.
    Gahm KH; Tan H; Liu J; Barnhart W; Eschelbach J; Notari S; Thomas S; Semin D; Cheetham J
    J Pharm Biomed Anal; 2008 Apr; 46(5):831-8. PubMed ID: 17531426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical carbon dioxide and in vitro evaluation].
    Liu H; Pan WS; Zhou LL; Zhang ZH
    Yao Xue Xue Bao; 2007 Feb; 42(2):206-10. PubMed ID: 17518053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral interconversion monitoring of a drug candidate by supercritical fluid chromatography (SFC).
    Mukherjee PS
    J Pharm Biomed Anal; 2009 Oct; 50(3):349-55. PubMed ID: 19487096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving sensitivity in chiral supercritical fluid chromatography for analysis of active pharmaceutical ingredients.
    Helmy R; Biba M; Zang J; Mao B; Fogelman K; Vlachos V; Hosek P; Welch CJ
    Chirality; 2007 Nov; 19(10):787-92. PubMed ID: 17722016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supercritical fluid-mediated methods to encapsulate drugs: recent advances and new opportunities.
    Naylor A; Lewis AL; Ilium L
    Ther Deliv; 2011 Dec; 2(12):1551-65. PubMed ID: 22833981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.